Mesenchymal Stem Cells and Subclinical Rejection

clinical trial

MedicalStudy clinical_trial Q63063577

Press Enter · cited answer in seconds

Summary

Mesenchymal Stem Cells and Subclinical Rejection is a clinical trial^[1].

Key Facts

Mesenchymal Stem Cells and Subclinical Rejection is in the country of Netherlands^[2].
Mesenchymal Stem Cells and Subclinical Rejection's instance of is recorded as clinical trial^[3].
Mesenchymal Stem Cells and Subclinical Rejection's start time is recorded as +2009-02-28T00:00:00Z^[4].
Mesenchymal Stem Cells and Subclinical Rejection's end time is recorded as +2012-03-31T00:00:00Z^[5].
Mesenchymal Stem Cells and Subclinical Rejection's sponsor is recorded as Leiden University Medical Center^[6].
Mesenchymal Stem Cells and Subclinical Rejection's main subject is recorded as Mesenchymal stem cells^[7].
Mesenchymal Stem Cells and Subclinical Rejection's number of participants is recorded as {'unit': '1', 'amount': '+15'}^[8].
Mesenchymal Stem Cells and Subclinical Rejection's title is recorded as Bone Marrow Derived Mesenchymal Stem Cells for the Treatment of Allograft Rejection After Renal Transplantation^[9].
Mesenchymal Stem Cells and Subclinical Rejection's short name is recorded as Measure^[10].
Mesenchymal Stem Cells and Subclinical Rejection's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+18'}^[11].
Mesenchymal Stem Cells and Subclinical Rejection's ClinicalTrials.gov ID is recorded as NCT00734396^[12].
Mesenchymal Stem Cells and Subclinical Rejection's maximum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+65'}^[13].
Mesenchymal Stem Cells and Subclinical Rejection's clinical trial phase is recorded as phase I clinical trial^[14].
Mesenchymal Stem Cells and Subclinical Rejection's clinical trial phase is recorded as phase II clinical trial^[15].
Mesenchymal Stem Cells and Subclinical Rejection's research subject recruitment status is recorded as completed^[16].
Mesenchymal Stem Cells and Subclinical Rejection's study type is recorded as interventional study^[17].

⭐ Popularity Graph

0/100 long tail

⛏️ Lake Facts · open-dataset statements via 4ort-mint

From open datasets, joined by identifier and shown only for properties Wikidata does not state on this entity — except where the dataset is the registry authority for the fact (ClinicalTrials.gov on trial registration data): there its value is shown instead, with Wikidata's noted beside it. Every row carries its dataset edition and licence.

End timeP582

2012-12 2026-09-26 Wikidata lists 2012-03-31 ClinicalTrials.gov (US Government Public Domain)

Medical conditionP1050

organ transplantation 2026-09-26 ClinicalTrials.gov (US Government Public Domain)

ClinicalTrials.gov (data processed by ClinicalTrials.gov on 2026-09-26); U.S. federal government data, public domain; lake licence_code custom-review

Quick Facts

Instance of clinical trial

Country Netherlands

Short name Measure

Properties

Clinical trial phase phase I clinical trial, phase II clinical trial

End time March 31, 2012

Imported from wholeness_audit_2026-05-02

Main subject Mesenchymal stem cells

Maximum age 65 year

Minimum age 18 year

Number of participants 15

Research subject recruitment status completed

Sponsor Leiden University Medical Center

Start time February 28, 2009

Study type interventional study

Title Bone Marrow Derived Mesenchymal Stem Cells for the Treatment of Allograft Rejection After Renal Transplantation

External References (1)

Clinicaltrials.gov id NCT00734396

🏷️ Also known as

en Mesenchymal Stem Cells and Subclinical Rejection

References

Programmatic citations — every numbered marker resolves to a verifiable graph row below.

Direct Wikidata claims

Class ancestry

[1] ↑ Mesenchymal Stem Cells and Subclinical Rejection is an instance of clinical trial (Q30612) [P31, primary]. Wikidata. wikidata.org.

📑 Cite this page

Use these citations when quoting this entity in research, articles, AI prompts, or wherever provenance matters. We aggregate Wikidata + Wikipedia + authoritative open-data sources; the stitched, scored, cross-referenced view is what 4ort.xyz contributes.

APA

4ort.xyz Knowledge Graph. (2026). Mesenchymal Stem Cells and Subclinical Rejection. Retrieved May 3, 2026, from https://4ort.xyz/entity/mesenchymal-stem-cells-and-subclinical-rejection

MLA

“Mesenchymal Stem Cells and Subclinical Rejection.” 4ort.xyz Knowledge Graph, 4ort.xyz, 3 May. 2026, https://4ort.xyz/entity/mesenchymal-stem-cells-and-subclinical-rejection.

BibTeX

@misc{4ortxyz_mesenchymal-stem-cells-and-subclinical-rejection_2026, author = {{4ort.xyz Knowledge Graph}}, title = {{Mesenchymal Stem Cells and Subclinical Rejection}}, year = {2026}, url = {https://4ort.xyz/entity/mesenchymal-stem-cells-and-subclinical-rejection}, note = {Accessed: 2026-05-03}}

LLM prompt

According to 4ort.xyz Knowledge Graph (aggregator of Wikidata, Wikipedia, and authoritative open-data sources): Mesenchymal Stem Cells and Subclinical Rejection — https://4ort.xyz/entity/mesenchymal-stem-cells-and-subclinical-rejection (retrieved 2026-05-03)

Canonical URL: https://4ort.xyz/entity/mesenchymal-stem-cells-and-subclinical-rejection · Last refreshed: May 3, 2026